Gottert Ann, Friedland Barbara A, Plagianos Marlena, Zieman Brady, Sales Jessica M, Atrio Jessica, Shetty Shakti, Sant'Anna Marinho Caio, Roselli Nicole, Merkatz Ruth, Bruce Irene, Haddad Lisa B
Population Council, Social and Behavioral Sciences Research, Washington, District of Columbia, USA.
Population Council, Center for Biomedical Research, New York, New York, USA.
Perspect Sex Reprod Health. 2025 Jun;57(2):144-153. doi: 10.1111/psrh.70009. Epub 2025 Apr 11.
Intravaginal rings (IVRs) are marketed or in development for contraception and other indications. We sought to develop and validate the IVR Acceptability Scale (IVR-AS) as a multidimensional, standardized tool for assessing IVR acceptability among end-users in the United States.
Scale items reflect specific aspects of IVR acceptability for women and male partners. Response options range from 1 (not-at-all acceptable) to 5 (highly acceptable). We evaluated the IVR-AS within a randomized, crossover clinical trial of three nonmedicated silicone IVRs of differing external diameters (46, 56, 66 mm) in heterosexual couples who used each for ~30 days, then completed a self-administered survey. We conducted exploratory factor analysis and multivariable regression to assess convergent validity. Follow-up in-depth interviews with all participants explored scale salience.
Twenty-four couples participated (mean age 27). The final 19-item women's scale (Cronbach's alpha = 0.93) included six subdimensions: ease of use; experience and sensation; effect on sexual desire/engagement, and effect on vaginal sex (all alphas > 0.78). The final eight-item men's scale comprised two subdimensions: effect on sexual desire/engagement and effect on vaginal sex (all alphas > 0.89). For both sexes, higher overall/subdimension scores were consistently associated with favorable assessments of the ring, for example, ease of insertion/removal; adherence (most p < 0.001). The 46/56 mm IVRs had higher overall and subdimension scores than the 66 mm IVR (most p < 0.001). Qualitative reports reinforced the salience of scale subdimensions and item content.
The IVR-AS captures multiple dimensions of IVR acceptability among women and their partners. The scales demonstrated excellent reliability and convergent validity. Further validation is warranted in future studies.
Clinical Trials.gov: NCT05128136. https://clinicaltrials.gov/study/NCT05128136?intr=non-medicated%20silicone%20ring&rank=2.
阴道环(IVR)已上市或正在研发用于避孕及其他适应症。我们试图开发并验证阴道环可接受性量表(IVR - AS),作为一种多维标准化工具,用于评估美国终端用户对阴道环的可接受性。
量表项目反映了女性及其男性伴侣对阴道环可接受性的具体方面。回答选项从1(完全不可接受)到5(高度可接受)。我们在一项随机交叉临床试验中评估了IVR - AS,该试验涉及三种不同外径(46、56、66毫米)的非药物硅胶阴道环,异性恋夫妇使用每种阴道环约30天,然后完成一份自我管理的调查问卷。我们进行了探索性因素分析和多变量回归以评估收敛效度。对所有参与者进行的后续深入访谈探讨了量表的显著性。
24对夫妇参与(平均年龄27岁)。最终的19项女性量表(克朗巴哈系数α = 0.93)包括六个子维度:易用性;体验和感觉;对性欲/性参与的影响,以及对阴道性行为的影响(所有α系数> 0.78)。最终的8项男性量表包括两个子维度:对性欲/性参与的影响和对阴道性行为的影响(所有α系数> 0.89)。对于两性而言,较高的总体/子维度得分始终与对阴道环的良好评价相关,例如,插入/取出的容易程度;依从性(大多数p < 0.001)。46/56毫米的阴道环比66毫米的阴道环具有更高的总体和子维度得分(大多数p < 0.001)。定性报告强化了量表子维度和项目内容的显著性。
IVR - AS涵盖了女性及其伴侣对阴道环可接受性的多个维度。这些量表显示出出色的信度和收敛效度。未来的研究有必要进行进一步验证。
ClinicalTrials.gov:NCT05128136。https://clinicaltrials.gov/study/NCT05128136?intr=non - medicated%20silicone%20ring&rank=2。